Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
DORA Trial: Phase 3 Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Study Status:
Open to Enrollment
Primary Investigator:
Date: May 13, 2019
AGCT1532: Phase 3 Accelerated BEP Trial: A Randomized Phase 3 trial of Accelerated vs Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 22, 2019
Pembrolizumab and Stereotactic Radio Surgery (SRS) of Selected Brain Metastases in Breast Cancer Patients
Study Status:
Open to Enrollment
Primary Investigator:
Date: April 5, 2019
Long term Outcomes of Obese Patients with Gastrointestinal Complications of Disease
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 25, 2019
ARO-021: Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Date: March 22, 2019
A Phase 1 Study With an Expansion Cohort/Randomized Phase 2 Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients With Relapsed/Refractory Hodgkin Lymphoma
Study Status:
Open to Enrollment
Primary Investigator:
Lisa Roth, MD
Date: February 21, 2019
Advanced Endoscopic Therapies (AETs): A Retrospective and Prospective Multicenter Registry
Study Status:
Open to Enrollment
Primary Investigator:
Reem Sharaiha, MD
Date: December 6, 2018
TARGET–NASH: A 5-year Longitudinal Observational Study of Patients with Non-Alcoholic Fatty Liver or Non-Alcoholic Steatohepatitis
Study Status:
Open to Enrollment
Primary Investigator:
Robert S. Brown, MD, MPH
Date: November 9, 2018
A Gene-Transfer, Open-Label, Dose-Escalation Study of SPK-8011 [Recombinant Adeno-Associated Viral Vector with B-Domain Deleted Human Factor VIII Gene] in Individuals with Hemophilia A
Study Status:
Open to Enrollment
Primary Investigator:
Catherine McGuinn
Date: November 2, 2018
IRONMAN: International Registry for Men with Advanced Prostate Cancer
Study Status:
Open to Enrollment
Primary Investigator:
Scott Tagawa, MD, MS
Date: September 25, 2018